Veli YAZISIZ et al. 2020. Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment. Archives of Rheumatology. 35, 2 (Jun. 2020), 300–302. DOI:https://doi.org/10.46497/ArchRheumatol.2020.7555.